Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rudolph

Showing results (191-200 of 249) with videos related to

Pageof 25
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 24, 2016
Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitorsHolger Kühne, Ulrike Obst-Sander, Bernd Kuhn, et al.
Journal of Computer-Aided Molecular Design|December 6, 2017
D3R Grand Challenge 2: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energiesZied Gaieb, Shuai Liu, Symon Gathiaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
A peptide that antagonizes TCR-mediated reactions with both syngeneic and allogeneic agonists: functional and structural aspectsMarkus G Rudolph, Lucy Q Shen, Stephen A Lamontagne, et al.
Journal of Medicinal Chemistry|February 16, 2016
A Real-World Perspective on Molecular DesignBernd Kuhn, Wolfgang Guba, Jérôme Hert, et al.
European Journal of Human Genetics : EJHG|June 15, 2000
Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degenerationF Krämer, K White, D Pauleikhoff, et al.
Elife|February 15, 2017
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibodyPaola Favuzza, Elena Guffart, Marco Tamborrini, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2010
Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetesHans G F Richter, Gregory M Benson, Denise Blum, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME propertiesHans G F Richter, G M Benson, K H Bleicher, et al.
Frontiers in Pharmacology|February 7, 2022
Synthesis, Characterization, and <i>in vivo</i> Evaluation of a Novel Potent Autotaxin-InhibitorDaniel Hunziker, Sabrina Reinehr, Marina Palmhof, et al.
The Journal of Biological Chemistry|May 27, 2016
Crystal Structures of the Human Doublecortin C- and N-terminal Domains in Complex with Specific AntibodiesDominique Burger, Martine Stihle, Ashwani Sharma, et al.
Pageof 25

Showing results (191-200 of 249) with videos related to

Sort By:
Pageof 25
Bioorganic & Medicinal Chemistry Letters|September 24, 2016
Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitorsHolger Kühne, Ulrike Obst-Sander, Bernd Kuhn, et al.
Journal of Computer-Aided Molecular Design|December 6, 2017
D3R Grand Challenge 2: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energiesZied Gaieb, Shuai Liu, Symon Gathiaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
A peptide that antagonizes TCR-mediated reactions with both syngeneic and allogeneic agonists: functional and structural aspectsMarkus G Rudolph, Lucy Q Shen, Stephen A Lamontagne, et al.
Journal of Medicinal Chemistry|February 16, 2016
A Real-World Perspective on Molecular DesignBernd Kuhn, Wolfgang Guba, Jérôme Hert, et al.
European Journal of Human Genetics : EJHG|June 15, 2000
Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degenerationF Krämer, K White, D Pauleikhoff, et al.
Elife|February 15, 2017
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibodyPaola Favuzza, Elena Guffart, Marco Tamborrini, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2010
Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetesHans G F Richter, Gregory M Benson, Denise Blum, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME propertiesHans G F Richter, G M Benson, K H Bleicher, et al.
Frontiers in Pharmacology|February 7, 2022
Synthesis, Characterization, and <i>in vivo</i> Evaluation of a Novel Potent Autotaxin-InhibitorDaniel Hunziker, Sabrina Reinehr, Marina Palmhof, et al.
The Journal of Biological Chemistry|May 27, 2016
Crystal Structures of the Human Doublecortin C- and N-terminal Domains in Complex with Specific AntibodiesDominique Burger, Martine Stihle, Ashwani Sharma, et al.
Pageof 25